![Hironori Narita](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Network origin in Hironori Narita first degree
Entity | Entity type | Industry | |
---|---|---|---|
DCI Partners KK
![]() DCI Partners KK Investment ManagersFinance DCI Partners KK (DCI Partners) is a venture arm of Daiwa Corporate Investment Co., Ltd. founded in 2014. The firm is headquartered in Tokyo, Japan.
4
| Subsidiary | Investment Managers | 4 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Hironori Narita via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
HOGY MEDICAL CO.,LTD. | Medical Specialties | Director/Board Member | |
AGP KK | Founder | ||
ASANTE INCORPORATED | Miscellaneous Commercial Services | Director/Board Member | |
KIDSWELL BIO CORPORATION | Biotechnology | Director/Board Member | |
Junten Bio Co. Ltd.
![]() Junten Bio Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Junten Bio Co. Ltd. is a Japanese company founded in 2018 that engages in research and development of cell and regenerative medicines. The company is based in Chuo-ku, Japan. | Miscellaneous Commercial Services | Director/Board Member | |
NOILE-IMMUNE BIOTECH INC. | Pharmaceuticals: Major | Director/Board Member | |
REGiMMUNE Corp.
![]() REGiMMUNE Corp. Pharmaceuticals: MajorHealth Technology REGiMMUNE Corp. develops solutions for treating immune disorders. Its focus is on the discovery, development, and commercialization of immune regulatory therapeutics to treat life-threatening and debilitating conditions, including allergies, autoimmune diseases and transplantation. The firm's platform technology, reVax, induces immune tolerance in an antigen-specific manner through pharmacological induction of regulatory T (Treg) cells. It also develops products for preventing inhibitor formation in enzyme replacement therapies (ERT) and for celiac disease with undisclosed partners. The company was founded by Yasuyuki Ishii on March 3, 2006 and is headquartered in Tokyo, Japan. | Pharmaceuticals: Major | Director/Board Member | |
University of Tsukuba | College/University | Graduate Degree | |
Tokyo University of Science | College/University | Graduate Degree | |
Daiwa Corporate Investment Co., Ltd.
![]() Daiwa Corporate Investment Co., Ltd. Investment ManagersFinance Daiwa Corporate Investment Co. Ltd. (Daiwa Corporate Investment) is a private equity arm of Daiwa Securities Group Inc. and is headquartered in Tokyo, Japan. The firm was founded in 1982. | Investment Managers | Comptroller/Controller/Auditor |
Statistics
International
Japan | 11 |
Sectoral
Health Technology | 5 |
Commercial Services | 3 |
Consumer Services | 3 |
Finance | 2 |
Operational
Director/Board Member | 10 |
Private Equity Investor | 3 |
Independent Dir/Board Member | 2 |
Graduate Degree | 2 |
Comptroller/Controller/Auditor | 2 |
Most connected contacts
Insiders | |
---|---|
Shuntaro Kodama | 7 |
Katsumi Uchida | 4 |
Hisaharu Momoshima | 2 |
Tadayuki Hatano | 1 |
- Stock Market
- Insiders
- Hironori Narita
- Company connections